Center for Cardiovascular Health Disparities Research at Meharry Medical College

该项目的长期目标是在梅哈里医学院（MMC）建立一个综合性心血管健康差异研究中心（CCHDR）。MMC，位于田纳西州纳什维尔，是最大的私人，历史上的黑人学术健康科学中心，专门致力于教育卫生保健专业人员和生物医学科学家。鉴于田纳西州，特别是北纳什维尔和波尔多/怀特克里克社区（MMC的初级卫生保健集水区）心血管疾病、中风和糖尿病的严重健康差异，CCHDR的发展对我们所服务的人群至关重要。这些地区大约有80-90%是非裔美国人。根据田纳西州卫生部门的统计，2005年（基于2000 - 2002年的数据）非裔美国人死于心脏病和中风的比率是田纳西州白人的1.5倍。同样，非裔美国人死于糖尿病（心脏病、中风和终末期肾病的主要危险因素）的死亡率是田纳西白人的两倍。考虑到总体情况，这些统计数据更加令人担忧

The long-range goal of this project is to establish a comprehensive Center for Cardiovascular Health Disparities Research (CCHDR) at Meharry Medical College (MMC). MMC, located in Nashville, TN., is the largest private, historically black academic health sciences center dedicated exclusively to educating health care professionals and biomedical scientists. Development of the CCHDR is critical to the population we serve given the severe health disparity in cardiovascular disease, stroke and diabetes in Tennessee and especially the North Nashville and Bordeaux/Whites Creek communities, primary health care catchment areas for MMC. These areas are approximately 80-90% African American. According to Tennessee Department of Health statistics, in 2005 (based on 2000 - 2002 data) the rate of death from heart disease and stroke in African Americans is one and a half times that of White Tennesseans. Likewise the death rate in African Americans from diabetes (a major risk factor for heart disease, stroke and end-stage renal disease) is twice that of White Tennesseans. These statistics are even more alarming given that overall Tennessee ranks the 3rd highest in the nation for cardiovascular-related deaths (Source: Tennessee Department of Health, Office of Policy, Planning and Assessment, Division of Health Statistics). The specifics aims of this Phase I application are to: 1. Establish an External Advisory Board of accomplished cardiovascular scientists with experience in developing and administering center programs. The External Advisory Board will assist in recruiting the senior cardiovascular scientist (see below); 2. Recruit a senior cardiovascular scientist with a history of sustained independent funding and leadership experience in research programs and/or centers; and 3. Develop a five-year strategic plan that will guide the development of the Phase II application.